Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1225 to 1232 of 1232 entries
Sorted by: Best Match Show Resources per page
Reopening of schools during COVID-19 pandemic: A persistent dilemma.

The Indian journal of medical research

Anand T, Bhargava B, Panda S.
PMID: 34596598
Indian J Med Res. 2021 May&Jun;153(5):572-576. doi: 10.4103/ijmr.ijmr_2805_21.

No abstract available.

Cite
Anand T, Bhargava B, Panda S. Reopening of schools during COVID-19 pandemic: A persistent dilemma. Indian J Med Res. 2021;153(5):572-576doi: 10.4103/ijmr.ijmr_2805_21.
Anand, T., Bhargava, B., & Panda, S. (2021). Reopening of schools during COVID-19 pandemic: A persistent dilemma. The Indian journal of medical research, 153(5), 572-576. https://doi.org/10.4103/ijmr.ijmr_2805_21
Anand, Tanu, et al. "Reopening of schools during COVID-19 pandemic: A persistent dilemma." The Indian journal of medical research vol. 153,5 (2021): 572-576. doi: https://doi.org/10.4103/ijmr.ijmr_2805_21
Anand T, Bhargava B, Panda S. Reopening of schools during COVID-19 pandemic: A persistent dilemma. Indian J Med Res. 2021 May&Jun;153(5):572-576. doi: 10.4103/ijmr.ijmr_2805_21. PMID: 34596598; PMCID: PMC8555613.
Copy Download .nbib Format: NLM
Comment on: Secondary impacts of constipation in acute lymphoblastic leukemia in US children's hospitals.

Pediatric blood & cancer

Naqvi R, Chatoo SA, Ahmad Z, D'Ignazio C, Bhargava R.
PMID: 34606162
Pediatr Blood Cancer. 2021 Oct 04;e29382. doi: 10.1002/pbc.29382. Epub 2021 Oct 04.

No abstract available.

Cite
Naqvi R, Chatoo SA, Ahmad Z, et al. Comment on: Secondary impacts of constipation in acute lymphoblastic leukemia in US children's hospitals. Pediatr Blood Cancer. 2021;e29382doi: 10.1002/pbc.29382.
Naqvi, R., Chatoo, S. A., Ahmad, Z., D'Ignazio, C., & Bhargava, R. (2021). Comment on: Secondary impacts of constipation in acute lymphoblastic leukemia in US children's hospitals. Pediatric blood & cancer, e29382. https://doi.org/10.1002/pbc.29382
Naqvi, Rameez, et al. "Comment on: Secondary impacts of constipation in acute lymphoblastic leukemia in US children's hospitals." Pediatric blood & cancer vol. (2021): e29382. doi: https://doi.org/10.1002/pbc.29382
Naqvi R, Chatoo SA, Ahmad Z, D'Ignazio C, Bhargava R. Comment on: Secondary impacts of constipation in acute lymphoblastic leukemia in US children's hospitals. Pediatr Blood Cancer. 2021 Oct 04;e29382. doi: 10.1002/pbc.29382. Epub 2021 Oct 04. PMID: 34606162.
Copy Download .nbib Format: NLM
A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis.

Journal of clinical and experimental dentistry

Mishra P, Bhargava A, Nigam-Gupta N.
PMID: 33841732
J Clin Exp Dent. 2021 Apr 01;13(4):e342-e349. doi: 10.4317/jced.57635. eCollection 2021 Apr.

BACKGROUND: Gingivitis is one of the most prevalent oral disease in humans. The most important etiological factor of gingivitis is dental plaque. Plaque control procedures comprises of several mechanical and chemical methods. Many studies have advocated that chemical plaque...

Cite
Mishra P, Bhargava A, Nigam-Gupta N. A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis. J Clin Exp Dent. 2021;13(4):e342-e349doi: 10.4317/jced.57635.
Mishra, P., Bhargava, A., & Nigam-Gupta, N. (2021). A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis. Journal of clinical and experimental dentistry, 13(4), e342-e349. https://doi.org/10.4317/jced.57635
Mishra, Priyanka, et al. "A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis." Journal of clinical and experimental dentistry vol. 13,4 (2021): e342-e349. doi: https://doi.org/10.4317/jced.57635
Mishra P, Bhargava A, Nigam-Gupta N. A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis. J Clin Exp Dent. 2021 Apr 01;13(4):e342-e349. doi: 10.4317/jced.57635. eCollection 2021 Apr. PMID: 33841732; PMCID: PMC8020310.
Copy Download .nbib Format: NLM
Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration.

Cells, tissues, organs

Panwar U, Mishra K, Patel P, Bharadva S, Vaniawala S, Shah A, Vundinti BR, Kothari SL, Ghosh K.
PMID: 34521091
Cells Tissues Organs. 2021;210(4):239-249. doi: 10.1159/000517423. Epub 2021 Sep 14.

The quantity of mesenchymal stem/stromal cells (MSCs) required for a particular therapy demands their subsequent expansion through ex vivo culture. During in vitro multiplication, they undergo replicative senescence which may alter their genetic stability. Therefore, this study was aimed...

Cite
Panwar U, Mishra K, Patel P, et al. Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration. Cells Tissues Organs. 2021;210(4):239-249doi: 10.1159/000517423.
Panwar, U., Mishra, K., Patel, P., Bharadva, S., Vaniawala, S., Shah, A., Vundinti, B. R., Kothari, S. L., & Ghosh, K. (2021). Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration. Cells, tissues, organs, 210(4), 239-249. https://doi.org/10.1159/000517423
Panwar, Urvi, et al. "Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration." Cells, tissues, organs vol. 210,4 (2021): 239-249. doi: https://doi.org/10.1159/000517423
Panwar U, Mishra K, Patel P, Bharadva S, Vaniawala S, Shah A, Vundinti BR, Kothari SL, Ghosh K. Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration. Cells Tissues Organs. 2021;210(4):239-249. doi: 10.1159/000517423. Epub 2021 Sep 14. PMID: 34521091.
Copy Download .nbib Format: NLM
Role of Transesophageal and Epicardial Echocardiography to Assess Surgical Repair in Double-Outlet Left Ventricle.

Journal of cardiothoracic and vascular anesthesia

Devarakonda BV, Nemani DN, Raja J, Dharan BS, Koshy T.
PMID: 33896712
J Cardiothorac Vasc Anesth. 2021 Mar 27; doi: 10.1053/j.jvca.2021.03.032. Epub 2021 Mar 27.

A double-outlet left ventricle (DOLV) is a congenital cardiac anomaly that rarely is encountered. This case report demonstrates the echocardiographic features of DOLV in the form of the pulmonary artery arising completely from the left ventricle with D-looped ventricles,...

Cite
Devarakonda BV, Nemani DN, Raja J, et al. Role of Transesophageal and Epicardial Echocardiography to Assess Surgical Repair in Double-Outlet Left Ventricle. J Cardiothorac Vasc Anesth. 2021;doi: 10.1053/j.jvca.2021.03.032.
Devarakonda, B. V., Nemani, D. N., Raja, J., Dharan, B. S., & Koshy, T. (2021). Role of Transesophageal and Epicardial Echocardiography to Assess Surgical Repair in Double-Outlet Left Ventricle. Journal of cardiothoracic and vascular anesthesia, . https://doi.org/10.1053/j.jvca.2021.03.032
Devarakonda, Bhargava V, et al. "Role of Transesophageal and Epicardial Echocardiography to Assess Surgical Repair in Double-Outlet Left Ventricle." Journal of cardiothoracic and vascular anesthesia vol. (2021). doi: https://doi.org/10.1053/j.jvca.2021.03.032
Devarakonda BV, Nemani DN, Raja J, Dharan BS, Koshy T. Role of Transesophageal and Epicardial Echocardiography to Assess Surgical Repair in Double-Outlet Left Ventricle. J Cardiothorac Vasc Anesth. 2021 Mar 27; doi: 10.1053/j.jvca.2021.03.032. Epub 2021 Mar 27. PMID: 33896712.
Copy Download .nbib Format: NLM
Global impact on dermatology practice due to the COVID-19 pandemic.

Clinics in dermatology

Bhargava S, Negbenebor N, Sadoughifar R, Ahmad S, Kroumpouzos G.
PMID: 34518007
Clin Dermatol. 2021 May-Jun;39(3):479-487. doi: 10.1016/j.clindermatol.2021.01.017. Epub 2021 Feb 02.

This contribution focuses on the effects of coronavirus disease 2019 (COVID-19) on dermatology practice. We discuss the impact on practice volume and procedures and on the considerable increase in teledermatology use. We also describe the important roles that dermatologists...

Cite
Bhargava S, Negbenebor N, Sadoughifar R, et al. Global impact on dermatology practice due to the COVID-19 pandemic. Clin Dermatol. 2021;39(3):479-487doi: 10.1016/j.clindermatol.2021.01.017.
Bhargava, S., Negbenebor, N., Sadoughifar, R., Ahmad, S., & Kroumpouzos, G. (2021). Global impact on dermatology practice due to the COVID-19 pandemic. Clinics in dermatology, 39(3), 479-487. https://doi.org/10.1016/j.clindermatol.2021.01.017
Bhargava, Shashank, et al. "Global impact on dermatology practice due to the COVID-19 pandemic." Clinics in dermatology vol. 39,3 (2021): 479-487. doi: https://doi.org/10.1016/j.clindermatol.2021.01.017
Bhargava S, Negbenebor N, Sadoughifar R, Ahmad S, Kroumpouzos G. Global impact on dermatology practice due to the COVID-19 pandemic. Clin Dermatol. 2021 May-Jun;39(3):479-487. doi: 10.1016/j.clindermatol.2021.01.017. Epub 2021 Feb 02. PMID: 34518007; PMCID: PMC8043816.
Copy Download .nbib Format: NLM
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival.

Journal for immunotherapy of cancer

Shah MA, Cunningham D, Metges JP, Van Cutsem E, Wainberg Z, Elboudwarej E, Lin KW, Turner S, Zavodovskaya M, Inzunza D, Liu J, Patterson SD, Zhou J, He J, Thai D, Bhargava P, Brachmann CB, Cantenacci DVT.
PMID: 34893523
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003580.

BACKGROUND: Matrix metalloproteinase-9 (MMP9) selectively cleaves extracellular matrix proteins contributing to tumor growth and an immunosuppressive microenvironment. This study evaluated andecaliximab (ADX), an inhibitor of MMP9, in combination with nivolumab (NIVO), for the treatment of advanced gastric cancer.METHODS: Phase...

Cite
Shah MA, Cunningham D, Metges JP, et al. Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. J Immunother Cancer. 2021;9(12)doi: 10.1136/jitc-2021-003580.
Shah, M. A., Cunningham, D., Metges, J. P., Van Cutsem, E., Wainberg, Z., Elboudwarej, E., Lin, K. W., Turner, S., Zavodovskaya, M., Inzunza, D., Liu, J., Patterson, S. D., Zhou, J., He, J., Thai, D., Bhargava, P., Brachmann, C. B., & Cantenacci, D. V. T. (2021). Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. Journal for immunotherapy of cancer, 9(12), . https://doi.org/10.1136/jitc-2021-003580
Shah, Manish A, et al. "Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival." Journal for immunotherapy of cancer vol. 9,12 (2021). doi: https://doi.org/10.1136/jitc-2021-003580
Shah MA, Cunningham D, Metges JP, Van Cutsem E, Wainberg Z, Elboudwarej E, Lin KW, Turner S, Zavodovskaya M, Inzunza D, Liu J, Patterson SD, Zhou J, He J, Thai D, Bhargava P, Brachmann CB, Cantenacci DVT. Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003580. PMID: 34893523.
Copy Download .nbib Format: NLM
Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia.

Blood research

Gajendra S, Gore AR, Jha B, Sood N, Bhargava M.
PMID: 34776413
Blood Res. 2021 Dec 31;56(4):339-342. doi: 10.5045/br.2021.2021093.

No abstract available.

Cite
Gajendra S, Gore AR, Jha B, et al. Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia. Blood Res. 2021;56(4):339-342doi: 10.5045/br.2021.2021093.
Gajendra, S., Gore, A. R., Jha, B., Sood, N., & Bhargava, M. (2021). Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia. Blood research, 56(4), 339-342. https://doi.org/10.5045/br.2021.2021093
Gajendra, Smeeta, et al. "Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia." Blood research vol. 56,4 (2021): 339-342. doi: https://doi.org/10.5045/br.2021.2021093
Gajendra S, Gore AR, Jha B, Sood N, Bhargava M. Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia. Blood Res. 2021 Dec 31;56(4):339-342. doi: 10.5045/br.2021.2021093. PMID: 34776413; PMCID: PMC8721456.
Copy Download .nbib Format: NLM
Showing 1225 to 1232 of 1232 entries